An interventional study of Pars Plana Vitrectomy in Retinal Detachment, sponsored by Minia University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 73 Years. Per ClinicalTrials.gov, last updated 2019-10-25.
Sponsored by Minia University · Not applicable, Interventional, and Treatment
Internal limiting membrane peeling is performed during vitrectomy for macular diseases such as macular holes, macular edema due to diabetic retinopathy and retinal vein occlusion.
The incidence of epiretinal membrane formation after vitrectomy for rhegmatogenous detachment has been reported to range from 4.4% to 12.8%.
In this study, the efficacy and safety of internal limiting membrane peeling will be studied in vitrectomy for rhegmatogenous retinal detachment and if it is essential to peel it in those cases or not.
interventional observational study comparing vitrectomy with versus without internal limiting membrane peeling in cases of rhegmatogenous retinal detachment.
207 studies on the registry are indexed under Retinal Detachment; 27 are open to participants now.
This study's enrollment of 60 is above the median of 50 across 136 interventional studies indexed under Retinal Detachment.
Browse Retinal Detachment studies →Minia University is the lead sponsor of 356 studies on the registry; 115 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
vitrectomy without ILM peeling is done to all cases
Other: Pars Plana Vitrectomy
vitrectomy with ILM peeling is done to all cases
Other: Pars Plana Vitrectomy
vitrectomy with and without ILM peeling
anatomical outcome
Rate of retinal reattachment using indirect ophthalmoscopy
Time frame: 6 months follow up
epiretinal membrane
incidence rate of epiretinal membrane formation after surgery in % percent
Time frame: 6 months follow up
functional outcome
visual functions using log Mar Best Corrected Visual Acuity (BCVA)
Time frame: 6 months follow up
superficial capillary density
measurement of percent (%) of superficial and deep capillary density using Optical Coherance Tomography Angiography
Time frame: 6 months follow up
multi-focal Electroretinogram
measurement of P1 amplitude
Time frame: 6 months follow up
Plan to share: No
This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Minia University